Abstract:This study investigates the compatibility of excipients with the model system SDI-X and their role in the induced crystallization of the amorphous compound-X in tablet formulations. We aimed to establish a straightforward and practical screening approach for evaluating excipient-induced crystallization of SDI in tablet matrices. Three methodologies-binary powder mixture, binary compact, and bilayer tablets-were employed to qualitatively and quantitatively evaluate the recrystallization of SDI-X with various excipients under accelerated storage conditions. The results demonstrated that binary compacts, providing direct physical contact between SDI-X and excipients, are superior in reflecting realistic drug-excipient contact within pharmaceutical tablets, enabling a more accurate assessment of excipient-induced crystallization for SDI-X. In contrast, the broadly used conventional binary blends can significantly underestimate this risk due to insufficient proximity. In addition, the bilayer tablets further confirmed that crystallization initiates at the contact surface between SDI-X and the excipients. The study highlighted that not only hygroscopicity but also the type of excipient and its physical contact with SDI-X significantly influence the recrystallization extent and rate of SDI-X. Interestingly, less hygroscopic diluents such as mannitol and lactose induced much higher levels of crystallization of SDIs, contrary to expectations based on moisture content alone. This suggests that the excipient type and contact surface are more critical in inducing recrystallization than just the level of moisture. The findings emphasize the need for careful excipient selection, study design, and sample preparation to enable appropriate assessments of SDI-excipient compatibility.

Selection of formulational excipients for the Qiyuejiangzhi tablets

Optimization of formulation for the Qiyuejiangzhi tablets

Preparation and Quality Control of Levamlodipine Besylate Orally Disintegrating Tablets

Optimization of preparation technique for the Qiyuejiangzhi tablets

Study on the molding process and quality standard of Qizhi Yifei granules

Optimization of Breviscapin Sustainded Release Tablets by Mixture Uniform Design

Formula Screening and Optimizing for the Dispersible Tablets of Breviscapinum

The Preparation Process of Huangqijing Effervescent Tablets

On Formula Optimization for Valaciclovir Dispersible Tablets

Influence of novel excipients on pharmaceutical qualities of compound Danshen tablets

The role of formulation excipients in the development of lyophilised fast-disintegrating tablets

Formulation Optimization and Preliminary Evaluation of Pluronic Thermosensitive in situ Gel with a Suspending Agent of Xanthan Gum

Studies on Sustained Release Hydrophilic Matrix Tablets Containing Hydroxypropylmethylceilulose and Carbopol

SELECTED EXCIPIENTS IN ORAL SOLID DOSAGE FORM WITH DRY EXTRACT OF PYROLA ROTUNDIFOLIA L.

Understanding Excipient-Induced Crystallization of Spray-Dried Amorphous Solid Dispersion

Optimal formulation and technology of captopril sustained-release tablet

Study on the New Processing Procedure and Quality Control for Multi-vitamins and Electrolytes Effervescent Tablets

A Novel Lactose/MCC/L-HPC Triple-Based Co-Processed Excipients with Improved Tableting Performance Designed for Metoclopramide Orally Disintegrating Tablets

Preparation of Weitengnin Dispersible Tablets

Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe

Optimization of Cudrania Extractum Tablets Formulation by Central Composite Design-Response Surface Methodology